Rubinstein Samuel 4

What Happened Samuel Rubinstein, a director of MediWound Ltd. (MDWD), acquired 150 ordinary shares on May 29, 2026 at $14.33 per share, for a total cash outlay of approximately $2,150. This was a purchase (reporting code P), a modest insider buy rather than a sale.

Key Details

• Transaction date: May 29, 2026; Price: $14.33 per share; Shares acquired: 150; Total ≈ $2,150.
• Filing date (Form 4): June 1, 2026. There is no indication in the provided filing that the report was late.
• Post-transaction total holdings: not specified in the excerpt provided.
• Footnotes of note:
  • F1: Some ordinary shares reported elsewhere in the filing represent shares underlying RSUs granted March 4, 2026 that vest 100% one year after the grant date (Mar 4, 2027).
  • F3: Options reported elsewhere were granted March 4, 2026 and vest 100% on the one-year anniversary.
  • F2: One row was included for informational purposes only and did not reflect an effected transaction.

Context

• Code P indicates a purchase; small purchases like this are factual signals of insider buying but are limited in size (~$2.1K) and may be routine.
• The RSU and option footnotes describe grants with one-year vesting — these are future-restricted holdings, not immediate cashless exercises or sales.